Dr. Vinit Karur, MD

Dr. Karur practices at NewYork-Presbyterian Hudson Valley Hospital in Cortlandt Manor, New York, part of NewYork-Presbyterian Hospital.

Dr. Karur's NPI, 1588825962, was assigned on June 19, 2008. Dr. Karur graduated from Baroda Medical College in 2000. Dr. Karur holds New York license 308153.

Dr. Karur's primary practice is NewYork-Presbyterian Hudson Valley Hospital, at 1980 Crompond Road, Cortlandt Manor, NY 10567 in Westchester County. The practice phone is (914) 734-3611.

Dr. Karur's primary practice is NewYork-Presbyterian Hudson Valley Hospital in Cortlandt Manor, New York, part of NewYork-Presbyterian Hospital. Dr. Karur is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is The Westchester Medical Practice. Dmand AI also links Dr. Karur to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karur practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Karur's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Karur is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Karur's licenses on file in 4 states: New York, Texas, New Jersey and Pennsylvania.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Karur treats.

CMS data shows 3,110 Medicare services from Dr. Karur across 8 procedure codes in 2024, for 381 Medicare patients. Medicare paid $224,923 for them.

CMS counts 381 Medicare patients who saw Dr. Karur in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karur's median patient age at 74, with 51% women.

In 2024, Dr. Karur wrote 1,432 Medicare Part D claims for 239 patients. 77% of them were for generic drugs. CMS names the drug for 1,133 of them, across 36 drugs with 11 or more claims each, at $2,644,484 in total drug cost. In 2023, CMS named 947 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Karur for performance year 2024, reported through an alternative payment model (APM). Dr. Karur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karur as offering telehealth.

Dmand AI links 10 papers to Dr. Karur, published from 2002 to 2023. 2006 was the busiest year, with 2. The most frequent topics are Erythropoiesis, Protein-Tyrosine Kinases and Anemia. Dr. Karur has published most often in Blood. Dr. Karur's most frequent co-authors are Rajat Bannerji, MD, PhD, Nadia Khan, MD and Clifford A. Lowell, MD.

Dmand AI links Dr. Karur to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Lymphoma, Follicular.

CMS Open Payments shows 14 general payments to Dr. Karur from 9 drug and device companies from 2016 to 2025. Education make up the largest share, 50% of the total. Janssen Pharmaceuticals, Inc paid the most, $203. It also lists 4 research payments totaling $1,265 in 2020.

Dmand AI lists 2 awards for Dr. Karur, most recently CMS Stage 1 EHR in 2013.

Dr. Karur graduated from Baroda Medical College in 2000. Dr. Karur is a member of ACP.

Dr. Karur is in network with 17 carriers, including Elevance, Aetna and MVP Health Care. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.